| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6021415 | Neurobiology of Disease | 2016 | 11 Pages |
Abstract
Noteworthy, the treatment with Aβ1-6A2VTAT(D) confers neuroprotection against both in vitro and in vivo synaptopathy models. Therefore Aβ1-6A2VTAT(D) may represent an innovative therapeutic tool to prevent synaptic degeneration in AD.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Sara Cimini, Alessandra Sclip, Simona Mancini, Laura Colombo, Massimo Messa, Alfredo Cagnotto, Giuseppe Di Fede, Fabrizio Tagliavini, Mario Salmona, Tiziana Borsello,